Compare Dr. Reddys with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs LAURUS LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB LAURUS LABS DR. REDDYS LAB/
LAURUS LABS
 
P/E (TTM) x 46.6 32.6 142.9% View Chart
P/BV x 4.5 13.3 33.7% View Chart
Dividend Yield % 0.5 0.3 169.9%  

Financials

 DR. REDDYS LAB   LAURUS LABS
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-21
LAURUS LABS
Mar-21
DR. REDDYS LAB/
LAURUS LABS
5-Yr Chart
Click to enlarge
High Rs5,515386 1,429.4%   
Low Rs3,02864 4,757.3%   
Sales per share (Unadj.) Rs1,145.489.7 1,276.8%  
Earnings per share (Unadj.) Rs114.518.3 624.3%  
Cash flow per share (Unadj.) Rs188.422.2 850.1%  
Dividends per share (Unadj.) Rs25.002.00 1,250.0%  
Dividend yield (eoy) %0.60.9 65.8%  
Book value per share (Unadj.) Rs1,053.248.3 2,179.9%  
Shares outstanding (eoy) m166.30536.60 31.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.72.5 148.9%   
Avg P/E ratio x37.312.3 304.4%  
P/CF ratio (eoy) x22.710.1 223.6%  
Price / Book Value ratio x4.14.7 87.2%  
Dividend payout %21.810.9 200.2%   
Avg Mkt Cap Rs m710,289120,585 589.0%   
No. of employees `000NANA-   
Total wages/salary Rs m36,2993,970 914.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m190,47548,135 395.7%  
Other income Rs m2,914237 1,231.6%   
Total revenues Rs m193,38948,372 399.8%   
Gross profit Rs m38,69915,507 249.6%  
Depreciation Rs m12,2882,051 599.2%   
Interest Rs m970682 142.3%   
Profit before tax Rs m28,35513,011 217.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,3193,173 293.7%   
Profit after tax Rs m19,0369,838 193.5%  
Gross profit margin %20.332.2 63.1%  
Effective tax rate %32.924.4 134.8%   
Net profit margin %10.020.4 48.9%  
BALANCE SHEET DATA
Current assets Rs m145,50330,749 473.2%   
Current liabilities Rs m81,03824,572 329.8%   
Net working cap to sales %33.812.8 263.7%  
Current ratio x1.81.3 143.5%  
Inventory Days Days6111 565.6%  
Debtors Days Days9510 960.5%  
Net fixed assets Rs m109,97926,758 411.0%   
Share capital Rs m8321,073 77.5%   
"Free" reserves Rs m174,31924,853 701.4%   
Net worth Rs m175,15125,926 675.6%   
Long term debt Rs m6,2994,292 146.8%   
Total assets Rs m255,48257,507 444.3%  
Interest coverage x30.220.1 150.5%   
Debt to equity ratio x00.2 21.7%  
Sales to assets ratio x0.70.8 89.1%   
Return on assets %7.818.3 42.8%  
Return on equity %10.937.9 28.6%  
Return on capital %16.245.3 35.7%  
Exports to sales %51.30-   
Imports to sales %18.134.4 52.5%   
Exports (fob) Rs m97,699NA-   
Imports (cif) Rs m34,42016,560 207.9%   
Fx inflow Rs m97,69933,250 293.8%   
Fx outflow Rs m34,42016,560 207.9%   
Net fx Rs m63,27916,690 379.1%   
CASH FLOW
From Operations Rs m35,7037,330 487.1%  
From Investments Rs m-22,660-9,410 240.8%  
From Financial Activity Rs m-2982,547 -11.7%  
Net Cashflow Rs m12,858468 2,749.2%  

Share Holding

Indian Promoters % 26.7 27.3 97.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 44.8 25.7 174.3%  
FIIs % 29.0 21.5 135.1%  
ADR/GDR % 12.1 0.0 -  
Free float % 61.2 72.7 84.2%  
Shareholders   223,309 299,257 74.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   NEULAND LABS  LINK PHARMA  EVEREST ORGANICS  PARENT.DRUGS  LASA SUPERGENERICS  



Today's Market

Sensex Ends 66 Points Lower; Bajaj Finance and Bajaj Finserv Among Top Nifty Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

LAURUS LABS Announces Quarterly Results (1QFY22); Net Profit Up 40.7% (Quarterly Result Update)

Jul 31, 2021 | Updated on Jul 31, 2021

For the quarter ended June 2021, LAURUS LABS has posted a net profit of Rs 2 bn (up 40.7% YoY). Sales on the other hand came in at Rs 13 bn (up 31.2% YoY). Read on for a complete analysis of LAURUS LABS 's quarterly results.

More Views on News

Most Popular

Make Startup Profits from Bluechip Stocks(Profit Hunter)

Jul 21, 2021

A 166-bagger stock can deliver even more gains in this decade.

These Are the Best Stocks to Own(Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

Cash the Crash in Gas Prices(Fast Profits Daily)

Jul 21, 2021

Get ready to profit from the coming crash in the price of natural gas.

Electric 2-Wheelers: The Megatrend has Begun(Profit Hunter)

Jul 20, 2021

The shift to electric 2-wheelers will be faster than expected.

A Trading Hack to Multiply Profits(Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Jul 30, 2021 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 8-QTR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS